DENTSPLY SIRONA Inc. (XRAY) Shares Sold by King Luther Capital Management Corp

King Luther Capital Management Corp trimmed its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 172,330 shares of the medical instruments supplier’s stock after selling 29,094 shares during the quarter. King Luther Capital Management Corp owned approximately 0.08% of DENTSPLY SIRONA worth $10,307,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Alps Advisors Inc. lifted its stake in shares of DENTSPLY SIRONA by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 20 shares in the last quarter. Wetherby Asset Management Inc. lifted its stake in shares of DENTSPLY SIRONA by 0.6% during the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock valued at $324,000 after buying an additional 30 shares in the last quarter. BRYN MAWR TRUST Co lifted its stake in shares of DENTSPLY SIRONA by 0.5% during the 2nd quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock valued at $782,000 after buying an additional 65 shares in the last quarter. Nordea Investment Management AB lifted its stake in shares of DENTSPLY SIRONA by 0.7% during the 2nd quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock valued at $664,000 after buying an additional 75 shares in the last quarter. Finally, Security National Bank of Sioux City Iowa IA lifted its stake in shares of DENTSPLY SIRONA by 0.4% during the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 23,081 shares of the medical instruments supplier’s stock valued at $1,497,000 after buying an additional 102 shares in the last quarter. Hedge funds and other institutional investors own 96.58% of the company’s stock.

Several analysts have issued reports on the stock. HC Wainwright cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 target price on the stock. in a research note on Thursday, November 30th. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price target on the stock in a report on Monday, November 6th. Morgan Stanley reissued an “overweight” rating and issued a $69.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Friday, October 6th. TheStreet lowered shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday, August 9th. Finally, Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $67.73.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at $65.61 on Wednesday. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. DENTSPLY SIRONA Inc. has a twelve month low of $52.53 and a twelve month high of $68.98. The company has a market cap of $15,177.45, a price-to-earnings ratio of 26.33, a P/E/G ratio of 2.62 and a beta of 1.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same quarter last year, the firm earned $0.66 EPS. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. research analysts forecast that DENTSPLY SIRONA Inc. will post 2.66 earnings per share for the current year.

In other news, CFO Nicholas W. Alexos purchased 50,000 shares of the company’s stock in a transaction on Monday, November 13th. The stock was acquired at an average price of $65.85 per share, with a total value of $3,292,500.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Mark Thierer purchased 77,000 shares of the company’s stock in a transaction on Monday, November 13th. The shares were purchased at an average cost of $66.04 per share, with a total value of $5,085,080.00. The disclosure for this purchase can be found here. 1.99% of the stock is currently owned by company insiders.

WARNING: “DENTSPLY SIRONA Inc. (XRAY) Shares Sold by King Luther Capital Management Corp” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this story can be read at https://www.chaffeybreeze.com/2017/12/06/dentsply-sirona-inc-xray-shares-sold-by-king-luther-capital-management-corp.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply